1. Continuous Temperature Telemonitoring of Patients with COVID-19 and Other Infectious Diseases Treated in Hospital-at-Home: Viture ® System Validation.
- Author
-
Sesma-Sánchez, Laura, Ruiz-Castellano, María, Romero-Roldán, Ainara, Álvarez-García, Laura, Morrás-Gómez, Marta, Tabar-Liberal, Idoia, Pulido-Fontes, Marta, and Salmón-García, Belén
- Subjects
- *
COVID-19 , *COMMUNICABLE diseases , *CLINICAL deterioration , *BODY temperature , *THERAPEUTICS , *FEVER - Abstract
Body temperature must be monitored in patients receiving Hospital-at-Home (HaH) care for COVID-19 and other infectious diseases. Continuous temperature telemonitoring (CTT) detects fever and patient deterioration early, facilitating decision-making. We performed a validation clinical study assessing the safety, comfort, and impact on healthcare practice of Viture®, a CTT system, compared with a standard digital axillary thermometer in 208 patients with COVID-19 and other infectious diseases treated in HaH at the Navarra University Hospital (HUN). Overall, 3258 pairs of measurements showed a clinical bias of −0.02 °C with limits of agreement of −0.96/+0.92 °C, a 95% acceptance rate, and a mean absolute deviation of 0.36 (SD 0.30) °C. Viture® detected 3 times more febrile episodes and revealed fever in 50% more patients compared with spot measurements. Febrile episodes were detected 7.23 h (mean) earlier and modified the diagnostic and/or therapeutic approach in 43.2% of patients. Viture® was validated for use in a clinical setting and was more effective in detecting febrile episodes than conventional methods. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF